medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2015, Number 3

<< Back Next >>

Acta Ortop Mex 2015; 29 (3)

Utility of morphogenetic protein for the treatment of congenital pseudoarthrosis of the tibia

Soria-Sánchez CR, López-Durán A, Isunza-Ramírez A

Language: Spanish
References: 26
Page: 182-185
PDF size: 511.03 Kb.


ABSTRACT

Objective: To report the ability of bone morphogenetic protein to achieve bone healing in patients with congenital pseudoarthrosis of the tibia. Patients and methods: Three patients with a diagnosis of congenital pseudoarthrosis of the tibia were followed-up for six months. Bone healing and functional capacity of the limb were observed. Results: Bone healing occurred in all cases at a mean of three and half months of treatment. Conclusions: Morphogenetic protein is useful as an adjuvant to achieve bone regeneration and healing in patients with congenital pseudoarthrosis of the tibia.


REFERENCES

  1. Andersen KS: Congenital pseudarthrosis of the leg: late results. J Bone Joint Surg Am. 1976; 58: 657-62.

  2. Boyd HB: Pathology and natural history of congenital pseudarthrosis of the tibia. Clin Orthop Relat Res. 1982; 166: 5-13.

  3. Johnston CE 2nd: Congenital pseudarthrosis of the tibia: results of technical variations in the Charnley-Williams procedure. J Bone Joint Surg Am. 2002; 84: 1799-810.

  4. Scottish Medicines Consortium. Dibotermin alfa (recombinant human bone morphogenetic protein-2/absorbable collagen sponge; rhBMP-2/ACS), 12 mg kit for implant. 6 April 2007 [Texto Completo] [Consulta: 21/09/2010]

  5. Crawford AH: Neurofibromatosis in children. Acta Orthop Scand Suppl. 1986; 218: 1-60.

  6. Boyd HB, Sage FP: Congenital pseudarthrosis of the tibia. J Bone Joint Surg Am. 1958; 40: 1245-379.

  7. Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P: Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B. 2000; 9: 3-10.

  8. Baker JK, Cain TE, Tullo HS: Intramedullary fixation for congenital pseudarthrosis of the tibia. J Bone Joint Surg Am. 1992; 74: 169-78.

  9. Vander HKL, Hensinger RN, Caird M: Congenital pseudarthrosis of the tibia. J Am Aca Ort Surg. 2008; 16: 228-36.

  10. Andersen KS: Congenital pseudarthrosis of the leg. Late results. J Bone Joint Surg Am. 1976; 58: 657-62.

  11. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL: Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg Am. 2004; 86: 1186-97.

  12. Paley D, Catagni M: Treatment of congenital pseudoartrosis of the tibia with the Ilizarov technique. Clin Orthop Relat Res. 1992; (280): 81-93.

  13. Paley D, Herzenberg J: Principles of deformity correction. 2nd ed. Springer; 2007: 101-356.

  14. Uribe RD: Pseudoartrosis congenital de la tibia. Capítulo 22. En: Ortopedia Infantil. Editorial Médica Panamericana; 2005: 252-65.

  15. Pho RW, Levack B: Preliminary obsevations on epiphyseal growth rate in congenital pseudoartrosis of the tibia after free vascularized fibular graft. Clin Orthop Relat Res. 1986; (206): 104-8.

  16. Ristiniemi J, Flinkkilä T, Hyvönen P, Lakovaara M, Pakarinen H, Jalovaara P: RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J Bone Joint Surg Br. 2007; 89(2): 265-72.

  17. Lee FY, Sinicropi SM, Lee FS, Vitale MG, Roye DP Jr, Choi IH: Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases. J Bone Joint Surg Am. 2006; 88(3): 627-33.

  18. Sutcliffe ML, Goldberg AA: The treatment of congenital pseudoratrosis of the tibia with pulsing electromagnetic field. A survey of 52 cases. Clin Orthop Relat Res. 1982; (166): 45-57.

  19. Jacobsen ST, Crawford AH, Millar EA, Steel HH: The Syme amputation in patients with congenital pseudarthrosis of the tibia. J Bone Joint Surg Am. 1983; 65: 533-7.

  20. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al: Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001; 83-A Suppl 1(Pt 2): S151-8.

  21. Govender S, et al: BMP-2 Evaluation in Surgery for Tibial Trauma Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84-A(12): 2123-34.

  22. Kim HW, Weinstein SL: Intramedullary fixation and bone grafting for congenital pseudoartrosis of the tibia. Clin Orthop Relat Res. 2002; (405): 250-7.

  23. Swiontkowski MF, Aro HT, Donell S, Esterhai JL, Goulet J, Jones A: Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am. 2006; 88(6): 1258-65.

  24. Traub JA, O’Connor W, Masso PD: Congenital pseudarthrosis of the tibia: a retrospective review. J Pediatr Orthop. 1999; 19(6): 735-8.

  25. Umber J, Moss S, Coleman S: Surgical treatment of the congenital pseudoartrosis of the tibia. Clin Orthop Relat Res. 1982; (166): 28-33.

  26. Wientroub S, Grill F: Congenital pseudarthrosis of the tibia: part 1. European Pediatric Orthopaedic Society multicenter study of congenital pseudarthrosis of the tibia. J Pediatr Orthop B. 2000; 9 (1): 1-2.




2020     |     www.medigraphic.com